NCT00128934View on ClinicalTrials.gov

Study Evaluating Combination of Levonorgestrel (LNG) and Ethinyl Estradiol (EE) in Premenstrual Dysphoric Disorder

PHASE3CompletedINTERVENTIONAL
Enrollment

744

Participants

Timeline

Start Date

August 31, 2005

Study Completion Date

December 31, 2007

Conditions
Menstruation DisturbancesPremenstrual Syndrome
Interventions
DRUG

levonorgestrel/ethinyl estradiol

Trial Locations (83)

10021

New York

11235

Brooklyn

14214

Buffalo

14609

Rochester

15090

Wexford

19104

Philadelphia

19114

Philadelphia

20037

Washington D.C.

21061

Glen Burnie

22903

Charlottesville

23230

Richmond

23233

Richmond

23294

Richmond

23502

Norfolk

27103

Winston-Salem

28304

Fayetteville

28562

New Bern

29654

Greer

29926

Hilton Head Island

30328

Atlanta

30342

Atlanta

31406

Savannah

33016

Hialeah

33024

Pembroke Pines

33180

Adventure

33407

West Palm Beach

33761

Clearwater

33916

Fort Myers

37203

Nashville

40509

Lexington

44122

Cleveland

44260

Mogadore

45219

Cincinnati

46601

South Bend

47714

Evansville

60631

Chicago

60634

Chicago

70114

New Orleans

72205

Little Rock

72401

Jonesboro

73112

Oklahoma City

74135

Tulsa

75010

Carrollton

77304

Conroe

78229

San Antonio

78756

Austin

80202

Denver

80228

Lakewood

80501

Longmont

83712

Boise

84070

Sandy City

84107

Salt Lake City

85251

Scottsdale

85715

Tucson

90095

Los Angeles

92103

San Diego

95608

Carmichael

97401

Eugene

97504

Medford

98055

Renton

98499

Lakewood

06457

Middletown

06510

New Haven

06708

Waterbury

02114

Boston

01201

Pittsfield

01107

Springfield

02914

East Providence

05401

Burlington

T6G 2C8

Edmonton

T6L 5X8

Edmonton

V1Y 2H4

Kelowna

V6H 3N1

Vancouver

L8N 4A6

Hamilton

M9W 4L6

Toronto

J9A 1K7

Hull

H1T 1P6

Montréal

H3A 1A1

Montréal

H9R 4S3

Pointe-Claire

G1R 2W8

Québec

G1S 2L6

Québec

G9N 2H6

Shawinigan

J1H 4J6

Sherbrooke

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00128934 - Study Evaluating Combination of Levonorgestrel (LNG) and Ethinyl Estradiol (EE) in Premenstrual Dysphoric Disorder | Biotech Hunter | Biotech Hunter